Andrographis paniculata extract: Clinical Trials

2 trials of Andrographis paniculata extract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Andrographis paniculata extract: new trials by email Literature Review of Andrographis paniculata extract trials Research Report on Andrographis paniculata extract

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis
HMPL-004, Placebo - Ulcerative Colitis
Phase 3TerminatedHutchison Medipharma Limited662013-06-012020-01-13
A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis
HMPL-004 1800 mg/day, Placebo, HMPL-004 2400 mg/day - Ulcerative Colitis
Phase 3TerminatedHutchison Medipharma Limited2012013-03-012020-01-02

Conditions studied

Colitis, Ulcerative (2)  ·  Lymphoma, Follicular (1)  ·  Motor Activity (1)

Sponsors

Hutchison Medipharma Limited (2)

Countries

United States (2)

Top investigators

Liu Rongjun, Dr. (1)  ·  Rongjun Liu, MD (1)